JP2011251968A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011251968A5 JP2011251968A5 JP2011138608A JP2011138608A JP2011251968A5 JP 2011251968 A5 JP2011251968 A5 JP 2011251968A5 JP 2011138608 A JP2011138608 A JP 2011138608A JP 2011138608 A JP2011138608 A JP 2011138608A JP 2011251968 A5 JP2011251968 A5 JP 2011251968A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutical composition
- composition according
- pivaloyl
- mesylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C(C1)[C@@](CO*)O[C@@]1N(C=C(C(*)=N1)F)C1=O Chemical compound *C(C1)[C@@](CO*)O[C@@]1N(C=C(C(*)=N1)F)C1=O 0.000 description 2
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10717898P | 1998-11-05 | 1998-11-05 | |
| US60/107,178 | 1998-11-05 | ||
| US11586299P | 1999-01-13 | 1999-01-13 | |
| US60/115,862 | 1999-01-13 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000579239A Division JP2002528510A (ja) | 1998-11-05 | 1999-11-05 | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011251968A JP2011251968A (ja) | 2011-12-15 |
| JP2011251968A5 true JP2011251968A5 (enExample) | 2012-09-06 |
Family
ID=26804484
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000579239A Withdrawn JP2002528510A (ja) | 1998-11-05 | 1999-11-05 | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
| JP2011138608A Pending JP2011251968A (ja) | 1998-11-05 | 2011-06-22 | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000579239A Withdrawn JP2002528510A (ja) | 1998-11-05 | 1999-11-05 | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1124565B1 (enExample) |
| JP (2) | JP2002528510A (enExample) |
| KR (1) | KR100679239B1 (enExample) |
| AT (1) | ATE321561T1 (enExample) |
| AU (1) | AU768059B2 (enExample) |
| BR (1) | BR9915037A (enExample) |
| CA (1) | CA2348948C (enExample) |
| DE (1) | DE69930678T2 (enExample) |
| ES (1) | ES2262366T3 (enExample) |
| IL (2) | IL142982A0 (enExample) |
| MX (1) | MXPA01004505A (enExample) |
| WO (1) | WO2000025799A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| JP5230052B2 (ja) | 2000-05-26 | 2013-07-10 | イデニクス（ケイマン）リミテツド | フラビウイルスおよびペスチウイルス治療のための方法および組成物 |
| NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| AP2005003213A0 (en) | 2002-06-28 | 2005-03-31 | Univ Cagliari | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections. |
| US7824851B2 (en) | 2002-11-15 | 2010-11-02 | Idenix Pharmaceuticals, Inc. | 2′-branched nucleosides and Flaviviridae mutation |
| MXPA05006230A (es) | 2002-12-12 | 2005-09-20 | Idenix Cayman Ltd | Proceso para la produccion de nucleosidos ramificados-2'. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD293498A5 (de) * | 1989-07-20 | 1991-09-05 | Zi Fuer Molekularbiologie Der Adw,De | Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier |
| WO1995007086A1 (en) * | 1993-09-10 | 1995-03-16 | Emory University | Nucleosides with anti-hepatitis b virus activity |
| BR9610120A (pt) * | 1995-09-07 | 1999-12-21 | Univ Georgia Res Found | Composição farmacêutica e processo para aumentar a meia vida de um medicamento em um indivìduo e para melhorar uma condição patológica em um paciente. |
| CN1268140A (zh) * | 1996-10-16 | 2000-09-27 | Icn药品公司 | 单环l－核苷、类似物及其应用 |
-
1999
- 1999-11-05 WO PCT/US1999/026156 patent/WO2000025799A1/en not_active Ceased
- 1999-11-05 JP JP2000579239A patent/JP2002528510A/ja not_active Withdrawn
- 1999-11-05 BR BR9915037-9A patent/BR9915037A/pt not_active IP Right Cessation
- 1999-11-05 EP EP99971324A patent/EP1124565B1/en not_active Expired - Lifetime
- 1999-11-05 CA CA002348948A patent/CA2348948C/en not_active Expired - Fee Related
- 1999-11-05 ES ES99971324T patent/ES2262366T3/es not_active Expired - Lifetime
- 1999-11-05 MX MXPA01004505A patent/MXPA01004505A/es active IP Right Grant
- 1999-11-05 IL IL14298299A patent/IL142982A0/xx unknown
- 1999-11-05 AU AU14691/00A patent/AU768059B2/en not_active Ceased
- 1999-11-05 DE DE69930678T patent/DE69930678T2/de not_active Expired - Lifetime
- 1999-11-05 KR KR1020017005695A patent/KR100679239B1/ko not_active Expired - Fee Related
- 1999-11-05 AT AT99971324T patent/ATE321561T1/de not_active IP Right Cessation
-
2001
- 2001-05-04 IL IL142982A patent/IL142982A/en not_active IP Right Cessation
-
2011
- 2011-06-22 JP JP2011138608A patent/JP2011251968A/ja active Pending